Original InvestigationZotarolimus-Eluting Versus Bare-Metal Stents in Uncertain Drug-Eluting Stent Candidates
Key Words
Abbreviations and Acronyms
Cited by (0)
The study is an investigator-driven clinical trial, which received funding from Medtronic through an unrestricted grant to the Consorzio Ferrara Ricerche, which employed dedicated personnel for data monitoring, data management, event adjudication, and independent statistical analysis.
Dr. Valgimigli has received honoraria for lectures/advisory board and research grants from Merck, Iroko, Eli Lilly, and Medtronic; honoraria for advisory board and lectures from The Medicines Company, Eli Lilly Co., Daiichi Sankyo, Inc., St. Jude, and Abbott Vascular; and fees for lectures from Cordis, CID, and Terumo. Dr. Patialiakas has received grants from the Hellenic Cardiological Society and the Hellenic Institution of Cardiology. Dr. McFadden has received fees from Abbott Vascular and Medtronic for Clinical Event Committee adjudications. Dr. Colangelo is a consultant for Abbott. Dr. Roffi has received institutional research grants from Abbott Vascular, Medtronic, Boston Scientific, Biotronik, and Biosensor. Dr. Ferlini has received consulting honoraria from Abbott Vascular and Eli Lilly. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.